Public expenditure on maternal health services per women -in reproductive age- with or without Social Security.

<p>Note: * Expressed in US$ and per women 15–49 years of age (at constant prices of 2011). **Includes women without any type of health insurance and those who reported being affiliated to the <i>Seguro Popular de Salud</i> (SPS).</p

Adequate antenatal care coverage and public expenditure in maternal health services among women -in reproductive age- with or without Social Security.

<p><b>PANEL A.</b> Social Security. <b>PANEL B.</b> Without Social Security*. Note: *Includes women without any type of health insurance and those who reported being affiliated to the Seguro Popular. **Adequate ANC (timely, ≥4 ANC visits + content of ANC ≥75% of basic procedures) were estimated using non-linear regression models (logit) adjusted by all population and contextual characteristics mentioned in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0152635#pone.0152635.t001" target="_blank">Table 1</a>. ***Expressed in US$ and per women 15–49 years of age (at constant prices of 2011).</p

Socio-demographics characteristics among women -in reproductive age- with or without Social Security.

<p>Socio-demographics characteristics among women -in reproductive age- with or without Social Security.</p

Lorenz curve and Gini index related to the public expenditure in maternal health services among women -in reproductive age- with or without Social Security.

<p>Note: Expressed in US$ and per women 15–49 years of age (at constant prices of 2011). **Includes women without any type of health insurance and those who reported being affiliated to the Seguro Popular.</p

Antennal care characteristics among women -in reproductive age- with or without Social Security.

<p>Antennal care characteristics among women -in reproductive age- with or without Social Security.</p

Involvement of Nrf2 signaling pathway in the cytoprotective actions of ginsenosides Rb1 and Rg1.

<p>(A) Degree of activation of Nrf2 factor in nuclear extracts of SH-SY5Y cells. (B) Effects of ginsenosides on Nrf2 protein levels in cytoplasm and (C) in nucleus; representative blots from purified cytoplasmic and nuclear fractions. Cells were pre-treated with ginsenosides for 24 h with/without later exposure to rotenone 50 μM for other 24 h. Data are expressed in percentage relative to untreated control cells. Means ± SD, * p < 0.05 Vs control, # p < 0.05 Vs rotenone-treated cells.</p

Sociodemographic and obstetric factors associated with cesarean section^‡.

<p>Source: Mexican National Nutrition Survey, 2012. Note: ^‡Adjusted logistic model. Estimates controlling for fixed effects by geographical region (Northwest, Northeast, Central-North, East, West, Central-South, Southwest, and Southeast). No statistically significant variables (p<0.10): 1–6 and 7–9 yrs. of schooling; Health Insurance; Indigenous (Ref.: Non-indigenous); Beneficiary of the Oportunidades program (Ref.: Non-beneficiary); Quantile of annual expenditure per resident: II–III; Urban and metropolitan area (Ref.: Rural); First prenatal consultation during the 1st trimester; Frequent prenatal care provider: Secretariat of Health and Private (Ref.: Social Security); Childbirth care provider: Secretariat of Health (Ref.: Social Security). Adjustment statistics: Akaike (AIC) = 8,159; Log likelihood = −4,042; Hosmer-Lemeshow χ2 = 12.8 (Prob> χ2 = 0.118).</p

Estimation of the molecular properties involved in the capacity of a compound to achieve passive diffusion through the BBB.

<p>Estimation of the molecular properties involved in the capacity of a compound to achieve passive diffusion through the BBB.</p

ORAC values obtained from the six ginsenosides screened for radical scavenging capacity.

<p>ORAC values obtained from the six ginsenosides screened for radical scavenging capacity.</p

Chemical structures for the two ginsenosides under study.

<p>Chemical structures for the two ginsenosides under study.</p